Trials / Not Yet Recruiting
Not Yet RecruitingNCT07482319
A Clinical Study GK01 Injection in Subjects With Advanced Malignant Solid Tumors
A Phase I, Open-label, Single-arm Clinical Study of GK01 Cell Injection in Patients With Advanced Malignant Solid Tumors
- Status
- Not Yet Recruiting
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 15 (estimated)
- Sponsor
- Beijing Geekgene Technology Co., LTD · Industry
- Sex
- All
- Age
- 18 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
An Open-label, Single-arm, Phase I Clinical Study of GK01 Cell Injection in the Treatment of Patients with Advanced Malignant Solid Tumors
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | GK01 injection | Autologous tumor-reactive T cells injection |
Timeline
- Start date
- 2026-04-01
- Primary completion
- 2026-12-01
- Completion
- 2028-04-01
- First posted
- 2026-03-19
- Last updated
- 2026-03-23
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT07482319. Inclusion in this directory is not an endorsement.